Lynne Powell
Directeur/Bestuurslid bij BIORA THERAPEUTICS, INC.
Vermogen: 3 488 $ op 30-04-2024
Profiel
Lynne M.
Powell is currently the Chief Executive Officer & Director at Tavanta Therapeutics, Inc. and an Independent Director at Biora Therapeutics, Inc. She was previously the Chief Executive Officer & Director at Druggability Technologies Holdings Ltd., Chief Commercial Officer & Senior Vice President at BioCryst Pharmaceuticals, Inc., and Senior VP-North American Commercial Operations at CSL Behring LLC.
Powell holds an MBA from Monash University and the University of Warwick, and an undergraduate degree from the University of East London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIORA THERAPEUTICS, INC.
0.02% | 01-03-2024 | 5 746 ( 0.02% ) | 3 488 $ | 30-04-2024 |
Actieve functies van Lynne Powell
| Bedrijven | Functie | Begin |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-02-2019 |
Tavanta Therapeutics, Inc.
 Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Algemeen Directeur | 01-09-2019 |
Eerdere bekende functies van Lynne Powell
| Bedrijven | Functie | Einde |
|---|---|---|
Druggability Technologies Holdings Ltd.
 Druggability Technologies Holdings Ltd. BiotechnologyHealth Technology Druggability Technologies Holdings Ltd., part of DRGT Holdco (Malta) Ltd., is a company headquartered in Dublin, Ireland. The firm develops proprietary drugs. | Algemeen Directeur | 01-10-2019 |
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2019 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01-10-2014 |
Opleiding van Lynne Powell
| Monash University | Masters Business Admin |
| University of Warwick | Masters Business Admin |
| University of East London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Bedrijven in privébezit | 3 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Druggability Technologies Holdings Ltd.
Druggability Technologies Holdings Ltd. BiotechnologyHealth Technology Druggability Technologies Holdings Ltd., part of DRGT Holdco (Malta) Ltd., is a company headquartered in Dublin, Ireland. The firm develops proprietary drugs. | Health Technology |
Tavanta Therapeutics, Inc.
Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Health Technology |
